Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arbutus Biopharma

3.44
+0.02730.80%
Volume:32.49K
Turnover:111.30K
Market Cap:658.17M
PE:-9.05
High:3.45
Open:3.40
Low:3.38
Close:3.41
Loading ...
Jan 13, 2020

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Jan 08, 2020

Correspondence

[Cover]Correspondence
Dec 23, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Dec 09, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Nov 05, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Oct 03, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 26, 2019

Major Issues Report

Current report, item 8.01
Aug 20, 2019

Major Issues Report

Current report, item 5.02
Aug 09, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 09, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 18, 2019

Major Issues Report

Current report, item 8.01
Jul 17, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jul 17, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jul 16, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jul 15, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 15, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities